Concepedia

Ewa Lech‐Marańda

EL

81

Publications

6.4K

Citations

35

H-Index

1999

Active since

Affiliations

Instytut Hematologii i Transfuzjologi(Current)

Medical University of Lodz

The Maria Sklodowska-Curie National Research Institute of Oncology

The University of Texas MD Anderson Cancer Center

Memorial Sloan Kettering Cancer Center

Ewa Lech‐Marańda is an author at Instytut Hematologii i Transfuzjologi specializing in medicine, hematology, and oncology.

ORCID

Top concepts

Publications per year

1999–2024

81

Publications

81

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

Hagop Kantarjian, Anthony S. Stein, Nicola Gökbuget et al. · New England Journal of Medicine · 2017 · 2K citations · Full text

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma

Joseph M. Connors, Wojciech Jurczak, David J. Straus et al. · New England Journal of Medicine · 2017 · 738 citations · Full text

Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study

Anthony R. Mato, Nirav N. Shah, Wojciech Jurczak et al. · The Lancet · 2021 · 432 citations · Full text

, , +6

Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia

Anthony R. Mato, Jennifer A. Woyach, Jennifer R. Brown et al. · New England Journal of Medicine · 2023 · 190 citations · Full text

Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma

Ewa Lech‐Marańda · Blood · 2004 · 184 citations · Full text

Rows per page

1–5 of 81